Cell Therapy News Volume 24.17 | May 15 2023

    0
    13








    2023-05-15 | CTN 24.17


    Cell Therapy News by STEMCELL Technologies
    Vol. 24.17 – 15 May, 2023
    TOP STORY

    An In Vivo Neuroimmune Organoid Model to Study Human Microglia Phenotypes

    The authors developed an in vivo xenotransplantation approach that allowed for the study of functionally mature human microglia that operated within a physiologically relevant, vascularized immunocompetent human brain organoid model.
    [Cell]

    Full ArticlePress ReleaseGraphical Abstract
    Learn about immunological considerations for hPSC banking by watching Dr. David Turner's webinar from the Nature Research Round Table on hPSC Quality
    PUBLICATIONSRanked by the impact factor of the journal

    Non-Invasive Activation of Intratumoral Gene Editing for Improved Adoptive T Cell Therapy in Solid Tumors

    Researchers reported a temperature-sensitive genome-editing nanodevice that could deliver a Cas9 editor with an external trigger which could be used to edit the genome of tumor cells to reduce resistance to apoptosis and modulate the tumor microenvironment via a mild heating trigger.
    [Nature Nanotechnology]

    Abstract

    Neonatal Tissue-Derived Extracellular Vesicle Therapy (NEXT): A Potent Strategy for Precision Regenerative Medicine

    The authors reported that NEXT was a potent strategy for precision tissue repair. Large amounts of extracellular vesicles with higher yield/purity could be readily isolated from desired tissues with less production time/cost compared to the conventional cell culture-based method.
    [Advanced Materials]

    Abstract

    Post-Translational Covalent Assembly of CAR and synNotch Receptors for Programmable Antigen Targeting

    To expand the targeting capabilities of these receptors, researchers developed “universal” receptor systems for which receptor specificity could be directed post-translationally via covalent attachment of a co-administered antibody bearing a benzylguanine motif.
    [Nature Communications]

    Full ArticlePress Release

    Enhanced Adipose Derived Stem Cells with IGF1 Modified mRNA Promote Wound Healing following Corneal Injury

    In order to explore an effective treatment that could achieve multi-dimensional repair of the injured cornea, the authors combined modified mRNA technologies with adipose-derived mesenchymal stem cell therapy.
    [Molecular Therapy]

    AbstractGraphical Abstract

    Hematopoietic Jagged1 Is a Fetal Liver Niche Factor Required for Functional Maturation and Engraftment of Fetal Hematopoietic Stem Cells

    Through the use of single-cell analysis and transplantation assays, investigators provided evidence of Jagged1 as a novel niche factor for fetal liver hematopoietic stem cells.
    [Proceedings Of The National Academy Of Sciences Of The United States Of America]

    Abstract

    Clinical-Grade Human Umbilical Cord-Derived Mesenchymal Stem Cells Improved Skeletal Muscle Dysfunction in Age-Associated Sarcopenia Mice

    Clinical-grade human umbilical cord-derived mesenchymal stem cells were administrated to two classic mouse models, and their effects on skeletal muscle mass and function were investigated by behavioral tests, immunostaining, and western blotting.
    [Cell Death & Disease]

    Full Article

    CD38 as a Pan-Hematologic Target for Chimeric Antigen Receptor T Cells

    In xenografted mice, CART-38-mediated rejection of acute myeloid leukemia, T cell acute lymphoblastic leukemia, and multiple myeloma cell lines and primary samples and prolonged survival.
    [Blood Advances]

    Abstract

    Single-Cell Transcriptome Analysis of Xenotransplanted Human Retinal Organoids Defines Two Migratory Cell Populations of Nonretinal Origin

    Investigators transplanted human retinal organoid-derived cells into photoreceptor-deficient mice and conducted histology and single-cell RNA sequencing alongside time-matched cultured retinal organoids.
    [Stem Cell Reports]

    Full Article

    Effects of Erythropoietin on Ischemia-Reperfusion When Administered before and after Ovarian Tissue Transplantation in Mice

    Scientists showed erythropoietin treatment after transplantation reduced ischemic damage in transplanted ovarian tissue, increased angiogenesis, maintenance of ovarian follicle proliferation, and reduced fibrosis areas in the grafted tissue.
    [Reproductive BioMedicine Online]

    Abstract
    Webinar on Modeling arrhythmias using hPSC-derived cardiomyocytes
    REVIEWS

    Development of Stem Cell Therapy for Atherosclerosis

    Investigators focus on recent research advances in stem cell therapy for atherosclerosis (AS) and briefly summarize the relevant factors that induce the formation of AS.
    [Molecular and Cellular Biochemistry]

    Abstract

    The Fate and Prospects of Stem Cell Therapy in the Treatment of Hypoxic-Ischemic Encephalopathy

    The authors discuss potential therapeutic mechanisms of stem cell transplantation for curing hypoxic-ischemic-induced brain injury, summarizing a series of approaches for marking transplanted cells and existing imaging systems for stem cell labeling.
    [European Journal of Neuroscience]

    Abstract
    INDUSTRY AND POLICY NEWS

    ImmPACT Bio Granted FDA Fast Track Designation for IMPT-314 in Patients with Relapsed or Refractory Aggressive B Cell Lymphoma

    ImmPACT Bio USA, Inc. announced the US FDA has granted Fast Track Designation for IMPT-314, a potential first-in-class CD19/CD20 CAR T therapy for the treatment of patients with B cell mediated malignancies.
    [ImmPACT Bio USA, Inc. (PRNewswire)]

    Press Release

    Maryland Stem Cell Research Commission Announces Over $14 Million in Awards to Accelerate Cures

    The Maryland Stem Cell Research Fund Commission has announced over $14.1 million in grant awards to promote innovative research that will strengthen and advance stem cell treatments and technologies in Maryland.
    [TEDCO]

    Press Release
    FEATURED EVENT

    ATC 2023

    June 3 – 7, 2023
    San Diego, California, United States

    > See All Events

    JOB OPPORTUNITIES

    Postdoctoral Fellow – Tumor Microenvironment

    Centre for Oncology and Immunology – Hong Kong, Hong Kong

    Production Manager – Equine MSCs

    Boehringer Ingelheim – Ingelheim, Germany

    Postdoctoral Scientist – Immunotherapy

    Max Delbrück Center for Molecular Medicine – Berlin, Germany

    Postdoctoral Fellow – Stem Cell and Regenerative Medicine

    Weill Cornell Medical College – New York, New York, United States

    Postdoctoral Research Associate – Oncology

    St. Jude Children’s Research Hospital – Memphis, Tennessee, United States

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    Cell Therapy News Twitter